Dr. Alexandrov received his MD degree in 1989 from the 1st Moscow Medical Institute (Sechenov), and specialized in clinical neurology at the Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia. He completed his fellowship training in stroke and cerebrovascular ultrasound at the University of Toronto with Dr. John W. Norris and at the University of Texas with Dr. James C. Grotta, and also received mentoring from Drs. Dmitry K. Lunev, Patrick M. Pullicino and Sandra E. Black.
Dr. Alexandrov is listed by US News&World Report among Best Doctors, America’s Top Doctors in Neurology in 2011-2014, and by Castle Connolly in the top 1% of specialists in Neurology in 2011-2017.
Dr. Alexandrov published 200 original papers, 3 textbooks, 16 case reports, 147 review articles, editorials, invited publications, and book chapters & over 310 abstracts presented at major scientific meetings and published in refereed journals. Current h-factor 60 (total citations 13510).
Dr. Alexandrov has trained 50 fellows in cerebrovascular ultrasound and stroke. He serves as Director of the Neurosonology Examination, Program Committee Chair and President-Elect of the American Society of Neuroimaging, Board member of the Intersocietal Accreditation Commission (IAC-Vascular), founding Editor-in-Chief (2011-2015),Brain and Behavior, Editorial Board member of Stroke, Cerebrovascular Diseases, International Journal of Stroke, Journal of Neuroimaging, The Stroke Interventionalist, and Annaly Klinicheskoi I Experimentalnoi Nevrologii and past member of the Society of Vascular and Interventional Neurology (SVIN) Board of Directors, and Program Committee, International Stroke Conference of the American Heart Association. He is an active elected member of the American Neurological Association.
Dr. Alexandrov holds a US patent and specializes in development of novel reperfusion therapies for stroke. He also serves as Medical Director of Mobile Stroke Unit, first in the world with state-of-the-art CT scanner performing head and neck CTA, and he also directs Memphis City-wide Stroke Program that achieved the highest treatment rates with t-PA in the world in 2015 and 2016.